Dhampur Bio Organics Ltd (DBOL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003689,
    "name": "Dhampur Bio",
    "stock_name": "Dhampur Bio",
    "full_name": "Dhampur Bio Organics Ltd",
    "name_url": "stocks-analysis/dhampur-bio",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "99.55",
    "chg": -2,
    "chgp": "-1.97%",
    "dir": -1,
    "prev_price": "101.55",
    "mcapval": "673.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543593,
    "symbol": "DBOL",
    "ind_name": "Sugar",
    "ind_code": 15,
    "indexname": "",
    "isin": "INE0I3401014",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "89.24 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/dhampur-bio-1003689-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Dhampur Bio Organics: Technical Momentum Shifts Amidst Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dhampur-bio-organics-sees-mixed-technical-signals-amid-price-momentum-shift-3743058",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DhampurBioOrgan_technicaldot_3743058.png",
        "date": "2025-12-03 08:09:14",
        "description": "Dhampur Bio Organics has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of market forces and technical indicators. This development comes amid a backdrop of mixed signals from key momentum and trend-following tools, underscoring the nuanced position of the stock within the sugar sector."
      },
      {
        "title": "Dhampur Bio Sees Revision in Market Evaluation Amid Challenging Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dhampur-bio-downgraded-to-strong-sell-amid-worsening-fundamentals-and-negative-financial-trends-3737983",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DhampurBio_mojoScore_3737983.png",
        "date": "2025-12-01 10:09:36",
        "description": "Dhampur Bio’s market evaluation has undergone a notable revision reflecting shifts in its fundamental and technical outlook. The sugar sector microcap’s recent assessment highlights ongoing operational challenges and market performance concerns, prompting a reassessment of its investment appeal."
      },
      {
        "title": "Why is Dhampur Bio falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dhampur-bio-fallingrising-3734411",
        "imagepath": "",
        "date": "2025-11-28 00:45:47",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Dhampur Bio’s stock has gained 7.69% over the past week, significantly outperforming the Sensex’s modest 0.10% rise during the same period. This recent rally includes a 7.9% return over the last two consecutive days, signalling renewed investor interest. The stock also outperformed its sector by 3.13% on the day, reaching an intraday high of ₹77.10, a 4.63% increase from the previous close. Despite this short-term strength, the stock remains below its longer-term moving averages, including the 50-day, 100-day, and 200-day averages, indicating that the rally is yet to fully reverse the broader downtrend.</p>\n<p>Trading volumes have also surged, with delivery volumes on 26 Nov rising by 110.14% compared to the five-day average, suggestin..."
      },
      {
        "title": "Dhampur Bio Organics Quarterly Performance Highlights Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dhampur-bio-organics-q2-2025-results-show-signs-of-stabilisation-amid-continued-losses-3717906",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DhampurBioOrgan_fintrenddot_3717906.png",
        "date": "2025-11-20 11:00:12",
        "description": "Dhampur Bio Organics, a key player in the sugar sector, has exhibited notable shifts in its recent quarterly financial performance. The company’s latest results for September 2025 reveal a transition from previously negative trends to a more neutral stance, reflecting a complex interplay of operational metrics and market conditions."
      },
      {
        "title": "Why is Dhampur Bio falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dhampur-bio-fallingrising-3703284",
        "imagepath": "",
        "date": "2025-11-14 23:53:39",
        "description": "As of 14-Nov, Dhampur Bio Organics Ltd is experiencing a decline in its stock price, currently at Rs 70.97, which reflects a decrease of Rs 2.43 or 3.31%. The stock has been underperforming significantly, having fallen for the last eight consecutive days, resulting in a total decline of 11.29% during this period. Additionally, the stock's performance over the past week shows a decrease of 6.99%, and it has generated a staggering return of -43.94% over the last year. The company is also trading below all its moving averages, indicating a bearish trend. Despite a slight increase in delivery volume, the overall sentiment remains negative due to the company's operating losses and a high debt-to-EBITDA ratio, which suggests weak long-term fundamental strength.\n\nIn the broader market context, the stock's performance is notably poor compared to the benchmark, as the Sensex has increased by 1.62% over the past week..."
      },
      {
        "title": "Dhampur Bio Organics Q2 FY26: Losses Deepen Amid Margin Collapse",
        "link": "https://www.marketsmojo.com/news/result-analysis/dhampur-bio-organics-q2-fy26-losses-deepen-amid-margin-collapse-3715508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DhampurBioOrgan_quaterlyResult_3715508.png",
        "date": "2025-11-14 09:45:03",
        "description": "Dhampur Bio Organics Limited reported a net loss of ₹15.99 crores in Q2 FY26, marking a deterioration of 27.32% quarter-on-quarter and a stark reversal from the ₹23.37 crore loss recorded in the corresponding quarter last year. The micro-cap sugar manufacturer, with a market capitalisation of ₹490.00 crores, continues to grapple with operational challenges despite posting revenue growth of 19.68% year-on-year to ₹557.69 crores. The stock has responded brutally to the sustained poor performance, plunging 44.20% over the past year and trading at ₹70.64 as of November 14, 2025, significantly below all key moving averages."
      },
      {
        "title": "How has been the historical performance of Dhampur Bio?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-dhampur-bio-3699752",
        "imagepath": "",
        "date": "2025-11-13 23:48:58",
        "description": "Answer:\nThe historical performance of Dhampur Bio shows fluctuations in key financial metrics over the past four years.\n\nBreakdown:\nDhampur Bio's net sales for the year ending March 2025 were reported at 1,861.54 crore, slightly down from 1,864.44 crore in March 2024 and significantly lower than 2,407.53 crore in March 2023. The total operating income mirrored this trend, remaining almost flat from the previous year but showing a decline from the prior two years. The total expenditure, excluding depreciation, was 1,726.74 crore in March 2025, a minor decrease from 1,728.01 crore in March 2024, yet lower than 2,202.81 crore in March 2023. Operating profit (PBDIT) for March 2025 was 138.46 crore, down from 160.30 crore in March 2024 and 216.14 crore in March 2023. Profit before tax also saw a decline to 15.71 crore in March 2025 from 65.49 crore in March 2024 and 134.77 crore in March 2023. Consequently, prof..."
      },
      {
        "title": "How has been the historical performance of Dhampur Bio?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-dhampur-bio-3695716",
        "imagepath": "",
        "date": "2025-11-13 00:36:39",
        "description": "Answer:\nThe historical performance of Dhampur Bio shows a fluctuating trend in key financial metrics over the past four years.\n\nBreakdown:\nIn terms of net sales, Dhampur Bio reported 1,861.54 Cr in March 2025, a slight decrease from 1,864.44 Cr in March 2024, and a significant drop from 2,407.53 Cr in March 2023. The total operating income mirrored this trend, with figures of 1,861.54 Cr in March 2025, 1,864.44 Cr in March 2024, and 2,407.53 Cr in March 2023. The total expenditure, excluding depreciation, was 1,726.74 Cr in March 2025, showing a decrease from 1,728.01 Cr in March 2024 and a notable decline from 2,202.81 Cr in March 2023. Operating profit (PBDIT) was 138.46 Cr in March 2025, down from 160.30 Cr in March 2024 and 216.14 Cr in March 2023. Profit before tax also decreased significantly to 15.71 Cr in March 2025 from 65.49 Cr in March 2024 and 134.77 Cr in March 2023. Consequently, profit after ..."
      },
      {
        "title": "When is the next results date for Dhampur Bio?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-dhampur-bio-3691265",
        "imagepath": "",
        "date": "2025-11-11 23:20:36",
        "description": "The next results date for Dhampur Bio is scheduled for 13 November 2025...."
      }
    ],
    "total": 327,
    "sid": "1003689",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/dhampur-bio-organics-1003689"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "23-Jan-2026",
      "details": "Pursuant to provisions of Regulation 47 of SEBI (LODR) Regulations 2015 please find attached copies of business standard wherein the unaudited financial results of the Company for the quarter and nine month ended December 31 2025 have been published.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Regarding The Complete Resumption Of Operations At Unit Mansurpur.",
      "datetime": "23-Jan-2026",
      "details": "In continuation to our earlier announcements and pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we wish to inform that the complete normalcy in the manufacturing operations of the Unit Mansurpur has been restored.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "22-Jan-2026",
      "details": "Investor Presentation on the performance of the Company for the quarter and nine month ended December 31 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dhampur Bio Organics Ltd has declared <strong>12%</strong> dividend, ex-date: 04 Jul 25",
          "dt": "2025-07-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Dhampur Bio Organics: Technical Momentum Shifts Amidst Mixed Market Signals

2025-12-03 08:09:14

Dhampur Bio Organics has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of market forces and technical indicators. This development comes amid a backdrop of mixed signals from key momentum and trend-following tools, underscoring the nuanced position of the stock within the sugar sector.

Dhampur Bio Sees Revision in Market Evaluation Amid Challenging Financials

2025-12-01 10:09:36

Dhampur Bio’s market evaluation has undergone a notable revision reflecting shifts in its fundamental and technical outlook. The sugar sector microcap’s recent assessment highlights ongoing operational challenges and market performance concerns, prompting a reassessment of its investment appeal.

Why is Dhampur Bio falling/rising?

2025-11-28 00:45:47

Recent Price Movement and Market Context Dhampur Bio’s stock has gained 7.69% over the past week, significantly outperforming the Sensex’s modest 0.10% rise during the same period. This recent rally includes a 7.9% return over the last two consecutive days, signalling renewed investor interest. The stock also outperformed its sector by 3.13% on the day, reaching an intraday high of ₹77.10, a 4.63% increase from the previous close. Despite this short-term strength, the stock remains below its longer-term moving averages, including the 50-day, 100-day, and 200-day averages, indicating that the rally is yet to fully reverse the broader downtrend. Trading volumes have also surged, with delivery volumes on 26 Nov rising by 110.14% compared to the five-day average, suggestin...

Dhampur Bio Organics Quarterly Performance Highlights Amid Market Challenges

2025-11-20 11:00:12

Dhampur Bio Organics, a key player in the sugar sector, has exhibited notable shifts in its recent quarterly financial performance. The company’s latest results for September 2025 reveal a transition from previously negative trends to a more neutral stance, reflecting a complex interplay of operational metrics and market conditions.

Why is Dhampur Bio falling/rising?

2025-11-14 23:53:39

As of 14-Nov, Dhampur Bio Organics Ltd is experiencing a decline in its stock price, currently at Rs 70.97, which reflects a decrease of Rs 2.43 or 3.31%. The stock has been underperforming significantly, having fallen for the last eight consecutive days, resulting in a total decline of 11.29% during this period. Additionally, the stock's performance over the past week shows a decrease of 6.99%, and it has generated a staggering return of -43.94% over the last year. The company is also trading below all its moving averages, indicating a bearish trend. Despite a slight increase in delivery volume, the overall sentiment remains negative due to the company's operating losses and a high debt-to-EBITDA ratio, which suggests weak long-term fundamental strength. In the broader market context, the stock's performance is notably poor compared to the benchmark, as the Sensex has increased by 1.62% over the past week...

Dhampur Bio Organics Q2 FY26: Losses Deepen Amid Margin Collapse

2025-11-14 09:45:03

Dhampur Bio Organics Limited reported a net loss of ₹15.99 crores in Q2 FY26, marking a deterioration of 27.32% quarter-on-quarter and a stark reversal from the ₹23.37 crore loss recorded in the corresponding quarter last year. The micro-cap sugar manufacturer, with a market capitalisation of ₹490.00 crores, continues to grapple with operational challenges despite posting revenue growth of 19.68% year-on-year to ₹557.69 crores. The stock has responded brutally to the sustained poor performance, plunging 44.20% over the past year and trading at ₹70.64 as of November 14, 2025, significantly below all key moving averages.

How has been the historical performance of Dhampur Bio?

2025-11-13 23:48:58

Answer: The historical performance of Dhampur Bio shows fluctuations in key financial metrics over the past four years. Breakdown: Dhampur Bio's net sales for the year ending March 2025 were reported at 1,861.54 crore, slightly down from 1,864.44 crore in March 2024 and significantly lower than 2,407.53 crore in March 2023. The total operating income mirrored this trend, remaining almost flat from the previous year but showing a decline from the prior two years. The total expenditure, excluding depreciation, was 1,726.74 crore in March 2025, a minor decrease from 1,728.01 crore in March 2024, yet lower than 2,202.81 crore in March 2023. Operating profit (PBDIT) for March 2025 was 138.46 crore, down from 160.30 crore in March 2024 and 216.14 crore in March 2023. Profit before tax also saw a decline to 15.71 crore in March 2025 from 65.49 crore in March 2024 and 134.77 crore in March 2023. Consequently, prof...

How has been the historical performance of Dhampur Bio?

2025-11-13 00:36:39

Answer: The historical performance of Dhampur Bio shows a fluctuating trend in key financial metrics over the past four years. Breakdown: In terms of net sales, Dhampur Bio reported 1,861.54 Cr in March 2025, a slight decrease from 1,864.44 Cr in March 2024, and a significant drop from 2,407.53 Cr in March 2023. The total operating income mirrored this trend, with figures of 1,861.54 Cr in March 2025, 1,864.44 Cr in March 2024, and 2,407.53 Cr in March 2023. The total expenditure, excluding depreciation, was 1,726.74 Cr in March 2025, showing a decrease from 1,728.01 Cr in March 2024 and a notable decline from 2,202.81 Cr in March 2023. Operating profit (PBDIT) was 138.46 Cr in March 2025, down from 160.30 Cr in March 2024 and 216.14 Cr in March 2023. Profit before tax also decreased significantly to 15.71 Cr in March 2025 from 65.49 Cr in March 2024 and 134.77 Cr in March 2023. Consequently, profit after ...

When is the next results date for Dhampur Bio?

2025-11-11 23:20:36

The next results date for Dhampur Bio is scheduled for 13 November 2025....

View All News